Global immunization: status, progress, challenges and future

Vaccines have made a major contribution to public health, including the eradication of one deadly disease, small pox, and the near eradication of another, poliomyelitis.Through the introduction of new vaccines, such as those against rotavirus and pneumococcal diseases, and with further improvements in coverage, vaccination can significantly contribute to the achievement of the health-related United Nations Millennium Development Goals.The Global Immunization Vision and Strategy (GIVS) was developed by WHO and UNICEF as a framework for strengthening national immunization programmes and protect as many people as possible against more diseases by expanding the reach of immunization, including new vaccines, to every eligible person.This paper briefly reviews global progress and challenges with respect to public vaccination programmes. The most striking recent achievement has been that of reduction of global measles mortality from an estimated 750,000 deaths in 2000 down to 197,000 in 2007. Global vaccination coverage trends continued to be positive. In 2007 most regions reached more than 80% of their target populations with three doses of DPT containing vaccines. However, the coverage remains well short of the 2010 goal on 90% coverage, particularly in the WHO region of Africa (estimated coverage 74%), and South-East Asia, (estimated coverage 69%). Elements that have contributed to the gain in immunization coverage include national multi-year planning, district-level planning and monitoring, re-establishment of outreach services and the establishment of national budget lines for immunization services strengthening. Remaining challenges include the need to: develop and implement strategies for reaching the difficult to reach; support evidence-based decisions to prioritize new vaccines for introduction; strengthening immunization systems to deliver new vaccines; expand vaccination to include older age groups; scale up vaccine preventable disease surveillance; improve quality of immunization coverage monitoring and use the data to improve programme performance; and explore financing options for reaching the GIVS goals, particularly in lower-middle income countries. Although introduction of new vaccines is important,this should not be at the expense of sustaining existing immunization activities. Instead the introduction of new vaccine introduction should be viewed as an opportunity to strengthen immunization systems, increase vaccine coverage and reduce inequities of access to immunization services.

[1]  R. Hutubessy,et al.  Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. , 2008, Bulletin of the World Health Organization.

[2]  Meeting of the immunization Strategic Advisory Group of Experts, November 2006--conclusions and recommendations. , 2007, Releve epidemiologique hebdomadaire.

[3]  S. Ellenberg,et al.  A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. , 2004, American journal of public health.

[4]  T. Cherian,et al.  A new global framework for immunization monitoring and surveillance. , 2007, Bulletin of the World Health Organization.

[5]  G. Wells,et al.  Evidence-based discussion increases childhood vaccination uptake: a randomised cluster controlled trial of knowledge translation in Pakistan , 2009, BMC international health and human rights.

[6]  T. Stapleton,et al.  The state of the world's children , 1987, Medical education.

[7]  T. Burton,et al.  Measurement of immunisation coverage , 2009, The Lancet.

[8]  Séraphin Simboro,et al.  Assessment of factors associated with complete immunization coverage in children aged 12-23 months: a cross-sectional study in Nouna district, Burkina Faso , 2009, BMC international health and human rights.

[9]  P. Duclos,et al.  Recommandations et politiques vaccinales mondiales : le rôle de l’OMS , 2007 .

[10]  Jill Turner,et al.  WORLD HEALTH ASSEMBLY , 1989, The Lancet.

[11]  Stephen S Lim,et al.  Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage , 2008, The Lancet.

[12]  S. Awasthi,et al.  Gender inequity and age-appropriate immunization coverage in India from 1992 to 2006 , 2009, BMC international health and human rights.

[13]  N. Andersson,et al.  Knowledge synthesis of benefits and adverse effects of measles vaccination: the Lasbela balance sheet , 2009 .

[14]  M. Wenner,et al.  Conclusions and recommendations , 2010, Annals of the New York Academy of Sciences.

[15]  P. Fournier,et al.  Monitoring the performance of the Expanded Program on Immunization: the case of Burkina Faso , 2009, BMC international health and human rights.

[16]  Tigran Nikoghosyan,et al.  United Nations Children’s Fund (UNICEF) , 2018, Yearbook of International Cooperation on Environment and Development 1998–99.

[17]  Rouslan Karimov,et al.  WHO and UNICEF estimates of national infant immunization coverage: methods and processes. , 2009, Bulletin of the World Health Organization.

[18]  A. Koumaré,et al.  Evaluation of immunization coverage within the Expanded Program on Immunization in Kita Circle, Mali: a cross-sectional survey , 2009, BMC international health and human rights.

[19]  P. Fournier,et al.  Determinants of parents' reticence toward vaccination in urban areas in Benin (West Africa) , 2009, BMC international health and human rights.

[20]  D. Kelly,et al.  Haemophilus influenzae type b conjugate vaccines , 2004, Immunology.

[21]  Steven Mitchell,et al.  Equity and vaccine uptake: a cross-sectional study of measles vaccination in Lasbela District, Pakistan. , 2009, BMC international health and human rights.

[22]  Gubler Mackenzie JS Japanese Encephalitis Vaccines ; WHO Position Paper Aug 2006 : Selected references Epidemiology of Japanese Encephalitis , 2022 .

[23]  Progress in global measles control and mortality reduction, 2000-2007. , 2008, Releve epidemiologique hebdomadaire.

[24]  Challenges in global immunization and the Global Immunization Vision and Strategy 2006-2015. , 2006, Releve epidemiologique hebdomadaire.

[25]  WHO position paper on Haemophilus influenzae type b conjugate vaccines. (Replaces WHO position paper on Hib vaccines previously published in the Weekly Epidemiological Record. , 2006, Releve epidemiologique hebdomadaire.

[26]  N. Andersson,et al.  One size does not fit all: local determinants of measles vaccination in four districts of Pakistan , 2009, BMC international health and human rights.

[27]  Peter M Strebel,et al.  Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study , 2007, The Lancet.

[28]  D. Nshimirimana,et al.  Reaching Every District (RED) approach: a way to improve immunization performance. , 2008, Bulletin of the World Health Organization.

[29]  F. Gasse,et al.  A new global immunisation vision and strategy , 2006, The Lancet.

[30]  B. Kouyaté,et al.  Portrait of a lengthy vaccination trajectory in Burkina Faso: from cultural acceptance of vaccines to actual immunization , 2009, BMC international health and human rights.

[31]  J. Kohler,et al.  The role of supportive supervision on immunization program outcome - a randomized field trial from Georgia. , 2009, BMC international health and human rights.

[32]  P. Fournier,et al.  System-level determinants of immunization coverage disparities among health districts in Burkina Faso: a multiple case study , 2009 .

[33]  B. Shea,et al.  Bmc International Health and Human Rights Increasing the Demand for Childhood Vaccination in Developing Countries: a Systematic Review , 2022 .

[34]  J. Andrus,et al.  Immunization and the Millennium Development Goals: progress and challenges in Latin America and the Caribbean. , 2008, Health affairs.

[35]  Organización Mundial de la Salud Typhoid vaccines: WHO position paper. , 2008, Releve epidemiologique hebdomadaire.